Cover Image

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response

Genetic polymorphisms in the gene encoding cytochrome P450 (CYP) 4F2, a vitamin K oxidase, affect stable warfarin dose requirements and time to therapeutic INR. CYP4F2 is part of the CYP4F gene cluster, which is highly polymorphic and exhibits a high degree of linkage disequilibrium, making it diffi...

Full description

Saved in:

Bibliographic Details
Main Authors:	J. E. Zhang (Author), Kathrin Klein (Author), Andrea L. Jorgensen (Author), Ben Francis (Author), Ana Alfirevic (Author), Stephane Bourgeois (Author), Panagiotis Deloukas (Author), Ulrich M. Zanger (Author), Munir Pirmohamed (Author)
Format:	Book
Published:	Frontiers Media S.A., 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathway-targeted pharmacogenomics of CYP1A2 in human liver
by: Kathrin eKlein, et al.
Published: (2010)

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers
by: Shanshan Nie, et al.
Published: (2022)

Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes-A Link in the Onset and Development of Cardiovascular Disease?
by: Benoit Drolet, et al.
Published: (2017)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019)

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: K. B. Mirzaev, et al.
Published: (2018)

Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke
by: Yuan Wu, et al.
Published: (2019)

EFFECT OF HIGH SALT ON RENAL NKCC2 IN CYP4F2 transgenic mice
by: Yanyan Zhao, et al.
Published: (2012)

A disease‐associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer
by: Elien Smeets, et al.
Published: (2022)

Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China
by: Huang K, et al.
Published: (2023)

Expression of CYP3A4 mRNA Is Correlated With CYP3A4 Protein Level and Metabolic Activity in Human Liver
by: Minoru Watanabe, et al.
Published: (2004)

<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005)

Renal NKCC2 Is Dual Regulated by the Synergy of 20-HETE and High-Fat Diet in CYP4F2 Transgenic Mice
by: Jingjing Wu, et al.
Published: (2021)

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities
by: Evelien G. E. Hurkmans, et al.
Published: (2020)

Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
by: Maria eThomas, et al.
Published: (2015)

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs
by: David Damoiseaux, et al.
Published: (2022)

Pleiotropic Effects of Ticagrelor: Influence on CYP4F2 Gene and Protein Expression in HUVEC and HepG2, and Escherichia coli Bacterial Survival
by: Meskauskaite U, et al.
Published: (2022)

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4
by: Mohamed Albadry, et al.
Published: (2024)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018)

CYP4 subfamily V member 2 (CYP4V2) polymorphisms were associated with ischemic stroke in Chinese Han population
by: Faqing Long, et al.
Published: (2022)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024)

The Dynamic Effect of Non-CYP3A4-Metabolized and CYP3A4-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
by: Hong Ting Shi, et al.
Published: (2021)

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride
by: Diana María Campodónico, et al.
Published: (2022)

Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer
by: Sm Faysal Bellah, et al.
Published: (2023)

Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5
by: Joseph M. Collins, et al.
Published: (2022)

Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon
by: José Pereira de Moura Neto, et al.
Published: (2023)

Utilization of Human Liver Microsomes to Explain Individual Differences in Paclitaxel Metabolism by CYP2C8 and CYP3A4
by: Ryoko Taniguchi, et al.
Published: (2005)

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
by: Decker BS, et al.
Published: (2013)

Exploring the Effect of Compound Glycyrrhizin and Silybinin on the Metabolism of Pexidartinib in Rats Based on CYP3A4 and CYP2C9
by: Yanding Su, et al.
Published: (2023)

Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
by: Saaket Agrawal, et al.
Published: (2020)

The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity
by: Zhuo-Qing Li, et al.
Published: (2018)

PBPK perspective on alternative CYP3A4 inducers for rifampin
by: Kuan‐Fu Chen, et al.
Published: (2022)

Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4
by: Liu W, et al.
Published: (2015)

Cloning and expression of SgCYP450-4 from Siraitia grosvenorii
by: Dongping Tu, et al.
Published: (2016)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction Predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2022)

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018)

Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform
by: Md Kabir, et al.
Published: (2022)

Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism
by: Nicola Ferri, et al.
Published: (2023)

Influence of Genetic Polymorphisms in CYP3A5, CYP3A4, and MDR1 on Tacrolimus Metabolism after kidney transplantation
by: Mirgul Bayanova, et al.
Published: (2024)

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
by: Qinglian Zhai, et al.
Published: (2024)

In vitro effects and in silico analysis of newly synthetized pyrrole derivatives on the activity of different isoforms of Cytochrome P450: CYP1A2, CYP2D6 and CYP3A4
by: Borislav Angelov, et al.
Published: (2022)